Availability of Transgene's 2023 Universal Registration Document
TRANSGENE (Paris: TNG) today announced that its Universal registration document for the fiscal year ended December 31, 2023, was submitted to the French stock market authority (Autorité des Marchés financiers – AMF) in ESEF format and registered under the reference D.24-0274.The 2023 Universal Registration Document is available to the public under the conditions provided by applicable regulations. The document is available on the Company's website: www.transgene.fr , in the...
Comunicato Precedente
Comunicato Successivo
Illkirch Graffenstaden,
(informazione.it - comunicati stampa - economia)
![](https://www.globenewswire.com/newsroom/ti?nf=MTAwMDkzNDI4NSM0MDE4MTczNjYjMTAxMTU0NA==)
TRANSGENE (Paris: TNG) today announced that its Universal registration document for the fiscal year ended December 31, 2023, was submitted to the French stock market authority (Autorité des Marchés financiers – AMF) in ESEF format and registered under the reference D.24-0274.
The 2023 Universal Registration Document is available to the public under the conditions provided by applicable regulations. The document is available on the Company's website: www.transgene.fr, in the “Investors/Financial information” section and on the AMF website: www.amf-france.org.
It includes:
- the 2023 annual financial report;
- the report of the Board of Directors on corporate governance;
- the statutory auditor's reports;
- information on the share buyback program;
- information related on the auditor's fees.
The universal registration document also includes information on the Company's environmental and social responsibility.
Contacts
Transgene: Lucie Larguier Chief Financial Officer +33 (0)3 88 27 91 04 [email protected] |
Attachment
- 20240411_Transgene_mise_a_disposition_URD_2023_EN
![](https://ml-eu.globenewswire.com/media/YmYwYjIxYTEtN2Q5NC00MmQ0LWIwZDktOWUyNTBhOTllM2Q3LTEwMTE1NDQ=/tiny/Transgene-S-A-.png)
Per maggiori informazioni
Sito Web
transgene.fr
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti